Treatment of H4IIE rat hepatoma and Hep3B human hepatoma cells with curcumin (2–50 μM) resulted in significantly reduced dexamethasone-induced PEPCK and G6Pase activity, indicating reduced gluconeogenesis (Table 2) [73]. This evidence concerns the gene G6PC1 and hepatocellular carcinoma.